Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Cancer

Explore clinical trials studying Head and Neck Cancer. Study availability and eligibility vary by location and protocol.

1,158 public trials 213 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Cancer trial results

Completed

High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer

NCT00002555

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France
  • CHR de Grenoble - La Tronche Grenoble, France
  • Centre Oscar Lambret Lille, France
View all 19 locations
View Trial Details
Completed

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

NCT00058006

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

NCT00017511

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +26 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Cranial Pain Research Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 71 locations
View Trial Details
Completed

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

NCT00503997

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
Locations
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Purchase Cancer Group - Paducah Paducah, Kentucky, United States
  • West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
View Trial Details
Completed

Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors

NCT00054977

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +31 more
Locations
  • Florida Oncology Associates Jacksonville, Florida, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

NCT00021047

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +43 more
Locations
  • Center for Cancer Research Bethesda, Maryland, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Naval Medical Center, Portsmouth Portsmouth, Virginia, United States
View Trial Details

Related conditions